Growth Metrics

Outset Medical (OM) Common Equity (2018 - 2026)

Outset Medical has reported Common Equity over the past 8 years, most recently at $127.0 million for Q4 2025.

  • Quarterly Common Equity rose 373.37% to $127.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.0 million through Dec 2025, up 373.37% year-over-year, with the annual reading at $127.0 million for FY2025, 373.37% up from the prior year.
  • Common Equity was $127.0 million for Q4 2025 at Outset Medical, down from $142.4 million in the prior quarter.
  • Over five years, Common Equity peaked at $431.2 million in Q2 2021 and troughed at $26.8 million in Q4 2024.
  • The 5-year median for Common Equity is $176.5 million (2023), against an average of $210.3 million.
  • Year-over-year, Common Equity plummeted 78.18% in 2024 and then skyrocketed 373.37% in 2025.
  • A 5-year view of Common Equity shows it stood at $374.1 million in 2021, then tumbled by 34.24% to $246.0 million in 2022, then crashed by 50.04% to $122.9 million in 2023, then plummeted by 78.18% to $26.8 million in 2024, then skyrocketed by 373.37% to $127.0 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Common Equity are $127.0 million (Q4 2025), $142.4 million (Q3 2025), and $154.8 million (Q2 2025).